Endometrial Cancer Therapy
Research from Nagoya University has provided new information about endometrial cancer therapy
Published in Women's Health Weekly, December 11th, 2008
New research, 'Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model,' is the subject of a report. "Indoleamine 2,3-dioxygenase (IDO) is a tryptophan-catabolizing enzyme that induces immune tolerance in mice. Our prior study showed that high tumoral IDO expression in endometrial cancer tissues correlates with disease progression and impaired patient survival," scientists in Nagoya, Japan report.
"The purpose of the present study was to clarify the functional role of IDO in human endometrial cancer cells and to investigate the therapeutic potential of IDO inhibitors. IDO cDNA was...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Imperial College London
Hairspray is linked to common genital birth defect, says study - JAMA and Archives Journals
Improvement seen regarding disparities for liver transplantation - Journal of the National Cancer Institute
Cancer incidence and mortality drops among American men and women, according to annual report - Journal of the National Cancer Institute
Pelvic lymphadenectomy does not improve survival in early stage endometrial cancer - Journal of the National Cancer Institute
Tracking and feedback registry may reduce racial disparities in breast cancer care - Louisiana State University Health Sciences Center
LSUHSC's Dr. Xiao Cheng Wu co-authors annual report to the nation on cancer - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
